Earlier this year, when FDA approved Merck's PD-1 inhibitor Keytruda (pembrolizumab) for “site-agnostic” indications, it raised new questions that will likely shape the future of oncology:
Philip Morris International, the tobacco company, is spending $1 billion over 12 years on “cancer research,” which will be funded through something called the Foundation for a Smoke-Free World.
Returning to Houston for a town hall meeting at MD Anderson on Sept. 27, Peter Pisters, the institution's freshly-appointed president, hit every note a guy in his position needed to hit: baseball, football, shared values, shared governance, book clubs, reminiscences on growing up nerdy in Canada, the story of how he met his wife, anecdotes from taking care of MD Anderson patients during Hurricane Rita.
In a 6-6 vote, ODAC says “maybe” to Sutent for adjuvant kidney cancer—
But at FDA “Maybe” has meaning
With frustrating photo finish voting results—6-6—still on the screen, FDA's cancer czar Richard Pazdur delivered an acerbic thank-you to members of the agency's Oncologic Drugs Advisory Committee:“Well, that's the end vote, it makes our job definitely easier,” said Pazdur, director of the FDA's Oncology Center of Excellence, who gets sarcastic sometimes.
Five UC Comprehensive Cancer Centers form consortium to pool patient data for translational research
Five academic cancer centers within the University of California system are putting together a single consortium to integrate their electronic health records, forming a clinical trials monolith that could be used by pharmaceutical companies doing research in the Golden State.
Douglas Lowy and John Schiller have won the 2017 Lasker-DeBakey Clinical Medical Research Award for research that led to development of the human papillomavirus vaccine.
Peter Pisters, a sarcoma and pancreatic cancer surgeon and an MD Anderson expat who serves as president and CEO of University Health Network of Toronto, is set to become the fifth president of the Houston-based cancer center.
Peter Pisters, a sarcoma surgeon and an MD Anderson expat who serves as president and CEO of University Health Network of Toronto, is set to become the fifth president of the Houston-based cancer center.
Project GENIE, a publicly available genomic data repository created and run by the American Association for Cancer Research, has amassed 18,804 de-identified records, and is on track to release another large dataset early this fall.
NCI and the Children's Oncology Group opened enrollment in Pediatric Molecular Analysis for Therapy Choice—Pediatric MATCH—a long-awaited precision medicine trial.
